pf-429242 has been researched along with Arenaviridae-Infections* in 2 studies
1 review(s) available for pf-429242 and Arenaviridae-Infections
Article | Year |
---|---|
Envelope glycoprotein of arenaviruses.
Arenaviruses include lethal human pathogens which pose serious public health threats. So far, no FDA approved vaccines are available against arenavirus infections, and therapeutic options are limited, making the identification of novel drug targets for the development of efficacious therapeutics an urgent need. Arenaviruses are comprised of two RNA genome segments and four proteins, the polymerase L, the envelope glycoprotein GP, the matrix protein Z, and the nucleoprotein NP. A crucial step in the arenavirus life-cycle is the biosynthesis and maturation of the GP precursor (GPC) by cellular signal peptidases and the cellular enzyme Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) yielding a tripartite mature GP complex formed by GP1/GP2 and a stable signal peptide (SSP). GPC cleavage by SKI-1/S1P is crucial for fusion competence and incorporation of mature GP into nascent budding virion particles. In a first part of our review, we cover basic aspects and newer developments in the biosynthesis of arenavirus GP and its molecular interaction with SKI-1/S1P. A second part will then highlight the potential of SKI-1/S1P-mediated processing of arenavirus GPC as a novel target for therapeutic intervention to combat human pathogenic arenaviruses. Topics: Amino Acid Sequence; Antiviral Agents; Arenaviridae Infections; Arenavirus; Glycosylation; Golgi Apparatus; Humans; Proprotein Convertases; Protein Sorting Signals; Proteolysis; Pyrrolidines; Receptors, Cell Surface; Serine Endopeptidases; Viral Envelope Proteins; Virus Assembly; Virus Attachment | 2012 |
1 other study(ies) available for pf-429242 and Arenaviridae-Infections
Article | Year |
---|---|
Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242.
The cellular protease subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P) is implicated in the proteolytic processing of the viral envelope glycoprotein precursor (GPC) of arenaviruses, a step strictly required for production of infectious progeny. The small molecule SKI-1/S1P inhibitor PF-429242 was shown to have anti-viral activity against Old World arenaviruses. Here we extended these studies and show that PF-429242 also inhibits GPC processing and productive infection of New World arenaviruses, making PF-429242 a broadly active anti-arenaviral drug. In combination therapy, PF-429242 potentiated the anti-viral activity of ribavirin, indicating a synergism between the two drugs. A hallmark of arenaviruses is their ability to establish persistent infection in vitro and in vivo. Notably, PF-429242 was able to efficiently and rapidly clear persistent infection by arenaviruses. Interruption of drug treatment did not result in re-emergence of infection, indicating that PF-429242 treatment leads to virus extinction. Topics: Amino Acid Sequence; Arenaviridae Infections; Arenaviruses, Old World; Base Sequence; Cell Line; Enzyme Inhibitors; Humans; Molecular Sequence Data; Proprotein Convertases; Pyrrolidines; Serine Endopeptidases | 2012 |